Genetic predictors of sporadic congenital heart defects in children

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Congenital heart defects can be embryopathies formed due to an imbalance in the processes of differentiation and proliferation in cardiac progenitor cells. One of the reasons for these disorders may be genetically restricted signaling, including that induced through Toll-like receptors (TLRs). Aim. To study the predictors in the TLRs genes for congenital heart defects. Material and methods. 80 children (39girls and 41 boys) with congenital heart defects requiring cardiac surgery were included in this study. The control group was formed from 96 healthy children. Four TLR genes were studied (TLR1 rs5743611, TLR1 rs5743551, TLR2 rs5743708, TLR2 rs3804099, TLR4 rs4986791, TLR4 rs4986790, TLR6 rs3775073 and TLR6 rs5743810). Genotyping was performed by real-time PCR using TaqMan probes. Results. This study showed that the combination of alleles in polymorphic sites of TLRs genes was statistically significant only for ventricular septal defects. The formation of ventricular septal defect is associated with homozygosity for the G allele in the TLR2 gene (rs5743708) and the T allele in the TLR6gene (rs3775073).

Full Text

Restricted Access

About the authors

Andrey Vladimirovich Shabaldin

Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases

Author for correspondence.
Email: weit2007@yandex.ru
Leading Researcher

Anna Viktorovna Tsepokina

Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases

Email: cepoav1991@gmail.com
junior researcher

Svetlana Alexandrovna Shmulevich

Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases

Email: shmulsa@kemcardio.ru
senior lecturer of the scientific and educational department

Anastasia Valerievna Ponasenko

Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases

Email: ponaav@kemcardio.ru
Head of the Laboratory of Genomic Medicine

References

  1. Саперова Е. В., Вахлова И. В. Врожденные пороки сердца у детей: распространенность, факторы риска, смертность. Вопросы современной педиатрии. 2017; 16 (2): 126-33. https://doi.org/10.15690/vsp.v16i2.1713
  2. Демикова Н.С., Лапина А.С., Подольная М.А., Путинцев А.Н. Значение генетических исследований в изучении природы врожденных пороков развития. Российский вестник перинатологии и педиатрии. 2020; 65 (5): 7-11. https://doi.org/10.21508/1027-4065-2020-65-5-7-11
  3. Нарциссова Г.П., Волкова И.И., Ленько О.А. Роль факторов риска пренатального периода в возникновении врожденных пороков сердца. Российский вестник перинатологии и педиатрии. 2014; 59 (5): 39-44
  4. Шабалов Н.П. Неонатология. М.: ГЭОТАР-Медиа, 2019; 704
  5. Шабалдин А.В., Цепокина А.В., Шмулевич С.А., Деева Н.С., Понасенко А.В., Антонова Л.В., Шабалдина Е.В. Особенности сочетаний полиморфных локусов гена триггерного рецептора, экспрессируемого миелоидными клетками (TREM-1), со спорадическими врожденными пороками сердца без хромосомных заболеваний. Медицинская иммунология. 2020; 22 (3): 507-18. https://doi.org/10.15789/1563-0625-A0P-1948
  6. Кувачева Н.В., Моргун А.В., Хилажева Е.Д., Малиновская Н.А., Горина Я.В., Пожиленкова Е.А., Салмина А.Б. Формирование инфламмасом: новые механизмы регуляции межклеточных взаимодействий и секреторной активности клеток. Сибирское медицинское обозрение. 2013; 5: 3-10
  7. Akira S. Toll receptor families: structure and function Semin Immunol. 2004; 16 (1): 1-2. https://doi.org/10.1016/j.smim.2003.10.001
  8. Frantz S., Ertl G. Bauersachs J. Mechanisms of Disease: Toll-like receptors in cardiovascular disease. Nat Rev Cardiol. 2007; 4 (8): 444-54. https://doi.org/10.1038/ncpcardio0938.
  9. Suluba E., Shuwe, L., Xia Q., Mwanga A. Congenital heart diseases: genetics, non-inherited risk factors, and signaling pathways. Egypt J. Med Hum Genet. 2020; 21 (1): 1-12. https://doi.org/10.1186/s43042-020-0050-1;
  10. McGettrick A. F., O'Neill L. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr. Opin. Immunol. 2010; 22 (1): 20-7. https://doi.org/10.1016/j.coi.2009.12.002
  11. Mikacenic C., Reiner A.P., Holden T.D., Nickerson D.A., Wurfel M.M. Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responses. Genes Immun. 2013; 14 (1): 52-7. https://doi.org/10.1038/gene.2012.53
  12. Qian C., Cao X. Regulation of Toll-like receptor signaling pathways in innate immune responses. Ann. N.Y. Acad. Sci. 2013; 1283: 67-74. https://doi.org/10.111Vj.1749-6632.2012.06786.x
  13. Полторак А.Н. Toll-подобные рецепторы как парадигма клетки. J. of Biomedical Technologies. 2014; 1: 52-7. [Poltorak A.N. Toll-like receptor as a paradigm of the cell. J. of Biomedical Technologies. 2014; 1: 52-7 (In Russian)]
  14. Жидкова И.И., Понасенко А.В., Хуторная М.В., Кутихин А.Г, Барбараш О.Л. Генетические факторы (гены рецепторов врожденного иммунитета -TLRs) в патогенезе атеросклероза и его осложнений. Медицинская иммунология. 2017; 19 (3): 241-54. https://doi.org/10.15789/1563-0625-2017-3-241-254
  15. Sharma S., Garg I., Ashraf M. Z. TLR signalling and association of TLR polymorphism with cardiovascular diseases. Vascular pharmacology 2016; 87: 30-7. https://doi.org/10.1016/j.vph.2016.10.008
  16. Ioana M., Ferwerda B., Plantinga T.S., Stappers M., Oosting M., McCall M., Cimpoeru A., Burada F, Panduru N., Sauerwein R., Doumbo O., van der Meer J.W., van Crevel R., Joosten L.A., Netea M.G. Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins. Infect. Immun. 2012; 80 (5): 1917-22. https://doi.org/10.1128/IAI.00121-12
  17. Крохалева Ю.А., Страмбовская Н.Н., Алферова А.Е. Генетический полиморфизм toll-рецепторов у больных ишемическим инсультом в Забайкальском крае. Забайкальский медицинский вестник. 2014; 4: 62-67
  18. Balistreri C.R., Candore G., Mirabile M., Lio D., Caimi G., Incalcaterra E., Caruso M., Hoffmann E., Caruso C. TLR2 and age-related diseases: potential effects of Arg753Gln and Arg677Trp polymorphisms in acute myocardial infarction. Rejuvenation Res. 2008; 11 (2): 293-6. https://doi.org/10.1089/rej.2008.0666
  19. Song Y, Liu H., Long L., Zhang N., Liu Y TLR4 rs1927911, but not TLR2 rs5743708, is associated with atherosclerotic cerebral Infarction in the Southern Han Population: a case-control study Medicine (Baltimore). 2015; 94 (2): e381. https://doi.org/10.1097/MD.0000000000000381.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. ROC analysis of the significance of predictors for congenital heart disease

Download (25KB)
3. Fig. 2. ROC-analysis of the significance of predictors for VSD

Download (20KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies